1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of obesity cases and smoking population
5.1.1.2. Rising incidences of the stomach cancer
5.1.1.3. Introduction of novel therapies for metastatic stomach cancer
5.1.1.4. Growing incidence of cancer cases and limited drugs as first-line treatment
5.1.2. Restraints
5.1.2.1. Stringent regulations and policies for approval of the drugs
5.1.3. Opportunities
5.1.3.1. Increase in awareness about the symptoms and causes of gastric cancer
5.1.3.2. Accelerating research and development activities
5.1.3.3. Rapid adoption of biosimilars in oncology
5.1.4. Challenges
5.1.4.1. High cost of therapy and lack of sufficient financial support from health insurance policies
5.2. Cumulative Impact of COVID-19

6. Gastric Cancer Drugs Market, by Route of Administration
6.1. Introduction
6.2. Oral
6.3. Parenteral

7. Gastric Cancer Drugs Market, by Lines of Chemotherapy
7.1. Introduction
7.2. First-line Chemotherapy
7.3. Second-line Chemotherapy

8. Gastric Cancer Drugs Market, by Molecule Type
8.1. Introduction
8.2. Biologics
8.3. Small Molecules

9. Americas Gastric Cancer Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Gastric Cancer Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Gastric Cancer Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Amgen Inc.
13.2. Arog Pharmaceuticals, Inc.
13.3. ASLAN Pharmaceuticals
13.4. AstraZeneca plc
13.5. Bayer AG
13.6. Bristol Myers Squibb company
13.7. Celltrion inc.
13.8. Eli Lilly and Company
13.9. F. Hoffmann-La Roche AG
13.10. Ipsen Biopharmaceuticals, Inc.
13.11. Merck & Co., Inc.
13.12. Novartis International AG
13.13. Pfizer Inc.
13.14. SELLAS Life Sciences Group, Inc.
13.15. Taiho Oncology, Inc.
13.16. Takeda Pharmaceutical Company Limited

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL GASTRIC CANCER DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL GASTRIC CANCER DRUGS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (%)
FIGURE 4. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 6. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY ORAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY PARENTERAL, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY LINES OF CHEMOTHERAPY, 2020 VS 2027 (%)
FIGURE 11. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY LINES OF CHEMOTHERAPY, 2020 VS 2027 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY LINES OF CHEMOTHERAPY, 2027
FIGURE 13. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY FIRST-LINE CHEMOTHERAPY, 2018-2027 (USD MILLION)
FIGURE 14. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY FIRST-LINE CHEMOTHERAPY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY SECOND-LINE CHEMOTHERAPY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY SECOND-LINE CHEMOTHERAPY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY MOLECULE TYPE, 2020 VS 2027 (%)
FIGURE 18. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY MOLECULE TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY MOLECULE TYPE, 2027
FIGURE 20. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY SMALL MOLECULES, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. AMERICAS GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 25. ARGENTINA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 26. BRAZIL GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 27. CANADA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. MEXICO GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. ASIA-PACIFIC GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. AUSTRALIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. CHINA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. INDIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. INDONESIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. JAPAN GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. MALAYSIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. PHILIPPINES GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. SINGAPORE GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. SOUTH KOREA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. TAIWAN GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. THAILAND GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. EUROPE, MIDDLE EAST & AFRICA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. FRANCE GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. GERMANY GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. ITALY GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. NETHERLANDS GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. QATAR GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. RUSSIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. SAUDI ARABIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. SOUTH AFRICA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. SPAIN GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. UNITED ARAB EMIRATES GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. UNITED KINGDOM GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. GLOBAL GASTRIC CANCER DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 55. GLOBAL GASTRIC CANCER DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL GASTRIC CANCER DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL GASTRIC CANCER DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY LINES OF CHEMOTHERAPY, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY FIRST-LINE CHEMOTHERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY SECOND-LINE CHEMOTHERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL GASTRIC CANCER DRUGS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. AMERICAS GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 13. ARGENTINA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 14. BRAZIL GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 15. CANADA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. MEXICO GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. AUSTRALIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. CHINA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. INDIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. INDONESIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. JAPAN GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. MALAYSIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. PHILIPPINES GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. SINGAPORE GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. SOUTH KOREA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. TAIWAN GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. THAILAND GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. FRANCE GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. GERMANY GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. ITALY GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. NETHERLANDS GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. QATAR GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. RUSSIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. SAUDI ARABIA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. SOUTH AFRICA GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. SPAIN GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. UNITED ARAB EMIRATES GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. UNITED KINGDOM GASTRIC CANCER DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL GASTRIC CANCER DRUGS MARKET: SCORES
TABLE 43. GLOBAL GASTRIC CANCER DRUGS MARKET: BUSINESS STRATEGY
TABLE 44. GLOBAL GASTRIC CANCER DRUGS MARKET: PRODUCT SATISFACTION
TABLE 45. GLOBAL GASTRIC CANCER DRUGS MARKET: RANKING
TABLE 46. GLOBAL GASTRIC CANCER DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 47. GLOBAL GASTRIC CANCER DRUGS MARKET: MERGER & ACQUISITION
TABLE 48. GLOBAL GASTRIC CANCER DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 49. GLOBAL GASTRIC CANCER DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 50. GLOBAL GASTRIC CANCER DRUGS MARKET: INVESTMENT & FUNDING
TABLE 51. GLOBAL GASTRIC CANCER DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 52. GLOBAL GASTRIC CANCER DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

Amgen Inc.
Arog Pharmaceuticals, Inc.
ASLAN Pharmaceuticals
AstraZeneca plc
Bayer AG
Bristol Myers Squibb company
Celltrion inc.
Eli Lilly and Company
F. Hoffmann-La Roche AG
Ipsen Biopharmaceuticals, Inc.
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
SELLAS Life Sciences Group, Inc.
Taiho Oncology, Inc.
Takeda Pharmaceutical Company Limited